| Term 
 
        | Metoprolol Tartrate   Brand Name: |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
|  Beta Blocker, beta -1 selective; antihypertensive,  antidysrhythmic  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
| Decreases heart rate, conduction velocity,  myocardial contractility, and cardiac output.  Used to control ventricular response in SVT (PSVT, atrial flutter).  Considered second line agent after adenosine, diltiazem, or digitalis derivative.  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
| PSVT, atrial flutter, atrial fibrillation,  reduces myocardial ischemia and  damage in patients with AMI |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
| Heart failure, second or   third degree AV block, first degree heart block  (if PR interval is equal or greater than 0.24 seconds),  sick sinus syndrome, cardiogenic shock,  bradycardia   |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Weakness, dizziness, depression, bronchospasm, wheezing, dyspnea, bradycardia, pulmonary edema, CHF, AV blocks, hypotension, heart failure, nausea, indigestion.    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
|  May cause a decrease in alertness, may  |  
|  Worsen s/s of heart failure in some  patients |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Adult: 5 mg slow IV push at 5 minute intervals to a total of 15 mg. hypertension dose is 100 mg daily po. Not to exceed 450 mg/day   Pedi: Safety not established    |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Blocker (beta-1 selective), Antidysrhythmic  |  | 
        |  | 
        
        | Term 
 
        |   Atenolol   Mechanism of Action:   |  | Definition 
 
        |   
| Decreases heart rate, myocardial contractility, and  cardiac output.  Inhibits dilation of bronchial smooth muscle.   |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     To reduce myocardial ischemia and damage in acute myocardial infarction patients; paroxysmal SVT, atrial flutter, atrial fibrillation, hypertension.       |  | 
        |  | 
        
        | Term 
 
        |    Atenolol   Contraindications:   |  | Definition 
 
        |   
| Heart failure, cardiogenic shock, bradycardia,  lung disease, hypotension, 2nd or 3rd degree  heart block.    |    |  | 
        |  | 
        
        | Term 
 
        |   Atenolol   Adverse Effects:   |  | Definition 
 
        |   Dizziness, bronchospasm, bradycardia, AV conduction delays, hypotension, myocardial infarction, heart failure.    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
|  Anti-hypertensive effects may be potentiated |  
|  When taken with Ca+ channel blockers or |  
|  MAOI’s, Sympathomimetic drugs may be  |  
|  Antagonized, hypoglycemia may be masked |    |  | 
        |  | 
        
        | Term 
 
        |    Atenolol   Dose & Administration:   |  | Definition 
 
        |   
| Adult: 5 mg slow IV (over 5 minutes).  Wait 10 minutes. Give second dose of 5 mg over  5 minutes.   Pedi: Not Recommended.  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Blocker, Antihypertensive  |  | 
        |  | 
        
        | Term 
 
        |   Propanolol   Mechanism of action:   |  | Definition 
 
        |   
|  Beta adrenergic blocker, reducing inotropic,  |  
|  Chronotropic & dromotropic effects of the heart |  
|  By antagonizing cardiac beta receptors |  
|  Is non selective |    |  | 
        |  | 
        
        | Term 
 
        |    Propanolol   Contraindications:   |  | Definition 
 
        |   
|  Sinus bradycardia, 2nd or 3rd degree heart block |  
|  Sick sinus syndrome (if no pacer present) |  
|  Asthma, cardiogenic shock, CHF |  
|  Pulmonary edema |    |  | 
        |  | 
        
        | Term 
 
        |    Propanolol   Dose & Administration   |  | Definition 
 
        |   
|  1 to 3 mg infused at 1 mg/min |    |  | 
        |  | 
        
        | Term 
 
        |    Heparin Sodium    Drug Class:   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |    Heparin Sodium    Mechanism of Action:   |  | Definition 
 
        |   
| Prevents conversion of fibrogen to fibrin.  Affects clotting factors IX, XI, XII, plasmin.  Does not destroy existing clots.    |    |  | 
        |  | 
        
        | Term 
 
        |    Heparin Sodium    Contraindications:   |  | Definition 
 
        |   
| Hypersensitivity, active bleeding, recent intracranial/ intraspinal/eyes surgery,  severe hypertension,  bleeding tendencies, severe thrombocytopenia  |    |  | 
        |  | 
        
        | Term 
 
        |    Heparin Sodium    Dose & Administration   |  | Definition 
 
        |       Adult: 60I units/kg IV bolus with max dose of 4000 units. Continuous infusion is given following the bolus at a rate of 12 units/kg/hr round to the nearest 50   Pedi: Not recommended        |  | 
        |  | 
        
        | Term 
 
        |    Heparin Sodium    Adverse Effects:   |  | Definition 
 
        |   Pain, anaphylaxis, shock, hematuria, GI bleeding, hemorrhage, thrombocytopenia, bruising.   |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        |   Furosemide   Mechanism of Action:   |  | Definition 
 
        |   Blocks the absorption of sodium and chloride at the distal and proximal tubules and the loop of Henle, causing increased urine output   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   CHF, Pulmonary edema, hypertensive crisis       |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Hypovolemia, anuria, hypotension (relative contraindication) hypersensitivity, hepatic coma, suspected electrolyte imbalances.    |  | 
        |  | 
        
        | Term 
 
        |   Furosemide   Adverse Effects:   |  | Definition 
 
        |   
| Dizziness, headache, ECG changes, weakness,  orthostatic hypotension, dysrhythmias, nausea,  vomiting, diarrhea, dry mouth, may exacerbate  hypovolemia and hypokalemia, hyperglycemia  (due to hemoconcentration)  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
|  Lithium and digitalis toxicity may develop |  
|  Due to changes in water balance.  **Many  |  
|  Negative consequences when incorrectly given |  
|  To patients with pneumonia** |    |  | 
        |  | 
        
        | Term 
 
        |    Furosemide   Dose & Administration:   |  | Definition 
 
        |   
| Adult: 0.5 – 1 mg/kg IV over 1 – 2 minutes.  If no response, double the dose to 2 mg/kg slowly over  1 -2 minutes. EMS standard dose is 40 mg for patients  not taking Lasix, and double home dose up to 80 mg  if patients are taking home Lasix.  Pedi: 1 mg/kg IV/IO |    |  | 
        |  |